Raines Heather 4
4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Dec 4, 2024
Insider Transaction Report
Form 4
Raines Heather
Chief Financial Officer
Transactions
- Award
Stock Options (Right to Buy)
2024-12-02+4,197,890→ 4,197,890 totalExercise: $0.29Exp: 2034-12-02→ Common Stock (4,197,890 underlying)
Footnotes (1)
- [F1]The options vest in three equal annual installments beginning on December 2, 2024.